The prevention of ventilator associated pneumonia in clinical practice - What can be done to lower the risk?

Mostert, Chris J.

Please note that UPSpace will be unavailable from Friday, 2 May at 18:00 (South African Time) until Sunday, 4 May at 20:00 due to scheduled system upgrades. We apologise for any inconvenience this may cause and appreciate your understanding.

Show simple item record

dc.contributor.author	Mostert, Chris J.
dc.date.accessioned	2008-08-06T08:25:17Z
dc.date.available	2008-08-06T08:25:17Z
dc.date.issued	2008-03
dc.description.abstract	Nosocomial infections are an important and frequent cause of morbidity and mortality in hospitals. Besides these factors, there are tremendous cost implications (reducing already scarce resources in taking care of our patients). Microorganisms that are resistant to multiple drugs are becoming prevalent worldwide. Common pathogens with resistance include extended spectrum beta lactamase Klebsiella pneumoniae and Escherichia Coli, vancomycin resistant Enterococci and vancomycin intermediate Staphylococcus aureus (VISA), penicillin resistant Streptococcus pneumoniae and multidrug resistant (MDR) Pseudomonas aeruginosa. It is therefore not surprising that antimicrobial resistance is becoming one of the greatest threats to patient health in the 21st century.	en
dc.format.extent	61071 bytes
dc.format.mimetype	application/pdf
dc.identifier.citation	Mostert, CJ 2008, 'The prevention of ventilator associated pneumonia in clinical practice - What can be done to lower the risk?', Professional Nursing Today, vol. 12, no. 2, pp. 14-16, [http://www.pntonline.co.za/index.php/PNT]	en
dc.identifier.issn	1607-6672
dc.identifier.uri	http://hdl.handle.net/2263/6493
dc.language.iso	en	en
dc.publisher	Medpharm Publications	en
dc.rights	Medpharm Publications	en
dc.subject	Ventilator-associated pneumonia	en
dc.subject	Pneumonia	en
dc.subject	Prevention	en
dc.subject	Clinical practice	en
dc.subject	Risk	en
dc.subject	Decreased risk	en
dc.subject	Risk factors	en
dc.subject	Pathogens	en
dc.subject	Preventative strategies	en
dc.subject	Intubation	en
dc.subject	Mechanical ventilation	en
dc.subject	Pathophysiology	en
dc.subject	Prophylaxis	en
dc.subject	Aspiration	en
dc.subject	Body position	en
dc.subject	Enteral feeding	en
dc.subject	Colonization	en
dc.subject	Stress bleeding	en
dc.subject	Transfusion	en
dc.subject	Hyperglycemia	en
dc.subject	Infection control	en
dc.subject	Strategies	en
dc.subject	Antimicrobial resistance	en
dc.subject	Klebsiella pneumoniae	en
dc.subject	Escherichia coli	en
dc.subject	Staphylococcus aureus	en
dc.subject	Pseudomonas aeruginosa	en
dc.subject.lcsh	Nosocomial infections
dc.subject.lcsh	Mortality
dc.subject.lcsh	Diseases
dc.subject.lcsh	Multidrug-resistant (MDR)
dc.subject.lcsh	Medical care, Cost of
dc.subject.lcsh	Microorganisms
dc.subject.lcsh	Klebsiella pneumoniae
dc.subject.lcsh	Escherichia coli
dc.subject.lcsh	Pseudomonas aeruginosa
dc.title	The prevention of ventilator associated pneumonia in clinical practice - What can be done to lower the risk?	en
dc.type	Article	en